Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01953276 · ClinicalTrials.gov registry record
Are Serial Electrocardiograms Additive to SeriAl Second-generations Troponins in Predicting Acute CoronAry Syndromes in PatienTs With Undifferentiated cHest Pain
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 382
- Enrollment target
NCT01953276 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 382 participants.
The verdict
NCT01953276 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 382 participants
- Enrollment target
Study Summary
Our research will examine whether the presence or absence of serial electrocardiogram (ECG) changes aids in reclassifying participants' risk for major adverse cardiac events (MACE) over and above serial blood testing.
Interventions
- DEVICE Serial Electrocardiograms
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 382 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01953276
The ClinicalTrials.gov registry entry for NCT01953276 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 382 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Serial Electrocardiograms is the first listed.
NCT01953276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01953276 about?
NCT01953276 is a clinical study titled "Are Serial Electrocardiograms Additive to SeriAl Second-generations Troponins in Predicting Acute CoronAry Syndromes in PatienTs With Undifferentiated cHest Pain". Our research will examine whether the presence or absence of serial electrocardiogram (ECG) changes aids in reclassifying participants' risk for major adverse cardiac events (MACE) over and above serial blood testing.
What is the current status of trial NCT01953276?
This trial is currently completed. The enrollment target is 382 participants. The study started on 2013-01. Estimated completion is 2018-01-15.
What interventions are being tested in trial NCT01953276?
The interventions under investigation include: Serial Electrocardiograms (DEVICE).
Who is sponsoring clinical trial NCT01953276?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.